Dr. Marshall P. Stagg

Our Lady of the Lake Physicians Group - Medical Oncology

Area of expertise

1Breast Cancer
Global Leader
Marshall P. Stagg has run 36 trials for Breast Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III
2Lung Cancer
Global Leader
Marshall P. Stagg has run 25 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Affiliated Hospitals

Image of trial facility.
Our Lady Of The Lake Physicians Group - Medical Oncology
Image of trial facility.
LSU Health Baton Rouge-North Clinic

Clinical Trials Marshall P. Stagg is currently running

Image of trial facility.

Mezigdomide + Carfilzomib + Dexamethasone

for Multiple Myeloma

The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.
Recruiting2 awards Phase 35 criteria
Image of trial facility.

Atezolizumab + Chemotherapy

for Neuroendocrine Carcinoma

This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). The other aim of this trial is to compare using atezolizumab just at the beginning of treatment versus continuing it beyond the initial treatment. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cisplatin and carboplatin are in a class of medications known as platinum-containing compounds that work by killing, stopping or slowing the growth of cancer cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. Giving atezolizumab in combination with a platinum drug (cisplatin or carboplatin) and etoposide may work better in treating patients with poorly differentiated extrapulmonary neuroendocrine cancer compared to standard therapy with a platinum drug (cisplatin or carboplatin) and etoposide alone.
Recruiting1 award Phase 2 & 310 criteria

More about Marshall P. Stagg

Clinical Trial Related4 years of experience running clinical trials · Led 36 trials as a Principal Investigator · 20 Active Clinical Trials
Treatments Marshall P. Stagg has experience with
  • Nivolumab
  • Atezolizumab
  • Carboplatin
  • Paclitaxel
  • Cisplatin
  • Fluorouracil

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marshall P. Stagg specialize in?
Marshall P. Stagg focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage I.
Is Marshall P. Stagg currently recruiting for clinical trials?
Yes, Marshall P. Stagg is currently recruiting for 18 clinical trials in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Marshall P. Stagg has studied deeply?
Yes, Marshall P. Stagg has studied treatments such as Nivolumab, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with Marshall P. Stagg?
Apply for one of the trials that Marshall P. Stagg is conducting. You can see the trials here.
What is the office address of Marshall P. Stagg?
The office of Marshall P. Stagg is located at:

Our Lady of the Lake Physicians Group - Medical Oncology,
Baton Rouge, Louisiana 70809
United States

This is the address for their practice at the Our Lady of the Lake Physicians Group - Medical Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.